Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United States”

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This MedicineActive Not Recruiting
NCT05846230Phase 2Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Australia, Belgium, Bulgaria, Canada +17 more
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell TransplantationRecruiting
NCT07573111Phase 1Updated Aug 21, 2026
Sponsor: Laguna Biotherapeutics, Inc.
Acute Leukemia · Myelodysplastic Syndrome
United States
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)Completed
NCT03940703Phase 2Updated Aug 21, 2026
Sponsor: EMD Serono Research & Development Institute, Inc.
Non-small Cell Lung Cancer
United States, Belgium, China, France, Germany +12 more
A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild AsthmaCompleted
NCT06702462Phase 1Updated Aug 21, 2026
Sponsor: GlaxoSmithKline
Asthma
United States
Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP)Not Yet Recruiting
NCT07756840Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Respiratory Recurrent Papillomatosis (RRP) · Human Papillomavirus (HPV) · Papillomavirus Infection · Laryngeal Diseases
United States
A Natural History of Cardiometabolic Disease Among US Bhutanese: Developing the Cross-Sectional Bhutanese Community of Central Ohio Health Study to Understand Acculturation as Synergizing Socioenvironmental and Biobehavioral Risk Factors Propagating ...Not Yet Recruiting
NCT06991751N/AUpdated Aug 21, 2026
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Cardiometabolic Risk Factors · Mental Health
United States
Dry Needling and Quad Strength After Anterior Cruciate Ligament ReconstructionNot Yet Recruiting
NCT07657195NAUpdated Aug 21, 2026
Sponsor: Children's Mercy Hospital Kansas City
Anterior Cruciate Ligament Reconstruction Rehabilitation · Dry Needling · Strength
United States
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting
NCT06897475Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Type 2 Diabetes
United States, Canada, Germany, Poland, Puerto Rico +1 more
Intervention on Mathematical Problem-Solving SkillsNot Yet Recruiting
NCT07778706NAUpdated Aug 21, 2026
Sponsor: Stanford University
Math Learning Disability · Learning Disabilities · Learning Disabilities, Child · Dyscalculia
United States
Assessment of Traumatic Brain Injury Using Transcranial Magnetic Stimulated Evoked PotentialsEnrolling By Invitation
NCT06963775N/AUpdated Aug 21, 2026
Sponsor: Ramon Diaz-Arrastia
Traumatic Brain Injury
United States
Amyloid PET Imaging in the Baltimore Longitudinal Study of AgingRecruiting
NCT07099053N/AUpdated Aug 21, 2026
Sponsor: National Institute on Aging (NIA)
Aging
United States
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary MalignanciesActive Not Recruiting
NCT04068194Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Locally Advanced Malignant Solid Neoplasm · Locally Advanced Unresectable Cholangiocarcinoma · Locally Advanced Unresectable Gallbladder Carcinoma · Locally Advanced Unresectable Malignant Solid Neoplasm
United States
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).Recruiting
NCT05947851Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Leukemia, Lymphocytic, Chronic, B-Cell · Leukemia, Chronic Lymphocytic · Small-Cell Lymphoma · Lymphoma, Small Lymphocytic
United States, Argentina, Australia, Belgium, Brazil +13 more
Alpelisib Challenge Test (ACT)Not Yet Recruiting
NCT07778524Phase 1Updated Aug 21, 2026
Sponsor: Columbia University
Insulin Resistance · Type 2 Diabetes · Obesity & Overweight · Healthy Adult Participants
United States
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaRecruiting
NCT06860594Phase 1Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Astrocytoma, IDH-Mutant, Grade 2 · Recurrent Adult Diffuse Hemispheric Glioma, H3 G34-Mutant · Recurrent Adult Diffuse Midline Glioma, H3 K27-Mutant · Recurrent Astrocytoma, IDH-Mutant
United States
Lacrifill for Ocular Surface Optimization in Cataract SurgeryRecruiting
NCT07648095N/AUpdated Aug 21, 2026
Sponsor: The Eye Institute of West Florida
Cataract
United States
REFOCUS-HTN US-WEST: A Data Infrastructure to Characterize Individuals With HypertensionRecruiting
NCT07780500N/AUpdated Aug 21, 2026
Sponsor: Kaiser Permanente
Hypertension · Aldosterone Disorder · Cardiovascular Disease (CVD)
United States
A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground TruthRecruiting
NCT07454603N/AUpdated Aug 21, 2026
Sponsor: Wren Laboratories LLC
Prostate Cancer · Urology · Prostate Cancer (Diagnosis)
United States
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are ToleratedRecruiting
NCT07553429Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Diabetic Macular Edema
United States, Puerto Rico
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)Recruiting
NCT07554339Phase 3Updated Aug 21, 2026
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Brazil, China +9 more
Understanding Mechanisms of Normal and Disordered DefecationRecruiting
NCT03842007NAUpdated Aug 21, 2026
Sponsor: Mayo Clinic
Constipation
United States
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerActive Not Recruiting
NCT06632327Phase 3Updated Aug 21, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Resectable Lung Non-Small Cell Carcinoma · Stage II Lung Cancer AJCC v8 · Stage IIIA Lung Cancer AJCC v8 · Stage IIIB Lung Cancer AJCC v8
United States
The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung CancerActive Not Recruiting
NCT04699123Phase 2Updated Aug 21, 2026
Sponsor: Yale University
Advanced Non-small Cell Lung Cancer
United States
Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back PainActive Not Recruiting
NCT06053242Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: Creative Medical Technology Holdings Inc
Chronic Low-back Pain · Degenerative Disc Disease
United States
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)Recruiting
NCT05125302Phase 3Updated Aug 21, 2026
Sponsor: AbbVie
Migraine
United States, Puerto Rico

Previous page Next page